Cancer Nanomedicine and Immune System—Interactions and Challenges
Nanoparticles have tremendous therapeutic potential in the treatment of cancer as they increase drug delivery, attenuate drug toxicity, and protect drugs from rapid clearance. Since Doxil®, the first FDA-approved nanomedicine, several other cancer nanomedicines have been approved and have successful...
Main Authors: | Suhana Ahmad, Ros Akmal Mohd Idris, Wan Nurhidayah Wan Hanaffi, Komathi Perumal, Jennifer C. Boer, Magdalena Plebanski, Juhana Jaafar, Jit Kang Lim, Rohimah Mohamud |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Nanotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnano.2021.681305/full |
Similar Items
-
Nanoparticles and Gut Microbiota in Colorectal Cancer
by: Komathi Perumal, et al.
Published: (2021-07-01) -
Causes and Consequences of Variable Tumor Cell Metabolism on Heritable Modifications and Tumor Evolution
by: Bryce Ordway, et al.
Published: (2020-03-01) -
A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy
by: Mohammad A. I. Al-Hatamleh, et al.
Published: (2019-01-01) -
Editorial: Current Perspectives, Challenges and Advances in Cell Based Therapies
by: Monica S. Thakar, et al.
Published: (2020-02-01) -
In-Vitro Approaches to Predict and Study T-Cell Mediated Hypersensitivity to Drugs
by: Sean Hammond, et al.
Published: (2021-04-01)